Claus Bornæs

OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.

Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland.

Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen.

Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.

Bankinvest Biomedical Venture provides investment services. The company was founded in 1998 and is headquartered in Copenhagen, Denmark.

AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.

Part of GN Store Nord A/S, FalCom A/S is a Danish company that manufactures hearing aids and parts. The company is based in Ballerup, Denmark.

STJ Advisors LLP provides capital markets advisory services. The private company is based in London, UK and has subsidiaries in Hong Kong. The British company was founded in 2008 by John James Moore St. John.

Dansk Erhverv is a business organization and employer association representing one of the world's most powerful business communities. The private company is based in Copenhagen, Denmark, and has subsidiaries in Denmark. With a membership of 18,000 companies and over 100 industry associations, the organization works daily to promote Denmark as the best country in the world to do business. The Danish company was founded by Tom Sten Behrens-Sørensen.

MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France.

Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.

Hearing Instrument Manufacturers Software Association A/S operates as private consortium company. It develops, markets, and supports Noah – one standard for integrated hearing care software. The company was founded in 1993 and is headquartered in Copenhagen, Denmark.

Confederation of Danish Industry operates as a business and employers organization for small and medium-sized enterprises. It serves manufacturing industry as well as sectors such as transportation, energy, information technology, health, trade, and professional services. The firm specializes in negotiation of collective agreements with labor unions; local, national, and international business regulations; and support for members on numerous services and relevant networks. The company is headquartered in Copenhagen, Denmark.

Part of Rodenstock GmbH, Rodenstock Holding GmbH is a company based in Munich, Germany. The CEOs of the German company are Oliver Kastalio, Marcus Enrico Desimoni, Anders Hedegaard, Roland Dimbath.

Eyewear Holding GmbH is an investment holding German company. The private company is based in Munich, Germany. The company was founded in 2006 and has three CEOs\: Marcus Enrico Desimoni, Anders Hedegaard, and Roland Dimbath.

Part of Rodenstock GmbH, Rodenstock Beteiligungen Ausland GmbH is a German company that provides management services. The company is based in Munich, Germany. The CEOs of the company are Anders Hedegaard, Antonio Arrigoni, Michael Kleer.

Ellab A/S engages in the provision of process validation and monitoring solutions used in the pharmaceutical, medical, and food industries. It offers calibration, training and consulting, qualification and validation, rental, and software support services. The company was founded by Jorgen Leo Nielsen in 1949 and is headquartered in Hillerod, Denmark.

Rodenstock GmbH engages in the design, manufacture and market of ophthalmic lenses and frames. It offers progressive lenses, computer glasses, distance glasses, driving glasses, reading glasses, sports glasses, children’s glasses, and sunglasses. The company was founded by Josef Rodenstock and Michael Rodenstock in 1877 and is headquartered in Munich, Germany.

7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark.

Foss A/S provides analytical instruments for the food, agricultural, chemical and pharmaceutical industries. It serves biofuel, central milk testing, feed and forage industries. The company was founded by Nils Utke Foss in 1956 and is headquartered in Hillerod, Denmark..

Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands.

Part of Bavarian Nordic A/S, Aktieselskabet af 1. juni 2011 II functions as an investment holding Danish company. The company is based in Kvistgard, Denmark.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

Natus Medical Denmark ApS develops, manufactures and markets computer-based audiological, otoneurologic and vestibular instruments. It offers hearing assessment, fitting systems, balance assessment, screening, software, and accessories solutions. The company was founded in 2001 and is headquartered in Taastrup, Denmark.

Lakeside Invest ApS provides financial services.